ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

P-Glycoprotein Function: Association with Race, Gender and Tacrolimus Pharmacokinetics.

K. Tornatore,1,4 H. Minderman,2 K. Attwood,3 K. O'Loughlin,2 R. Venuto.4

1Translational Pharmacology Research, School of Pharmacy, Buffalo
2Flow Cytometry Laboratory, Roswell Park Cancer Institute, Buffalo
3Biostatistics, School of Public Health, Buffalo
4Medicine, School of Medicine;UB, Buffalo.

Meeting: 2016 American Transplant Congress

Abstract number: 335

Keywords: African-American, Immunosuppression, Kidney transplantation, P-glycoprotein

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Medication Errors, Variability and Adherence

Session Time: 4:30pm-6:00pm

 Presentation Time: 5:06pm-5:18pm

Location: Room 302

Related Abstracts
  • Influence of Race on P-Glycoprotein Function in Peripheral Blood Mononuclear Cells
  • Pharmacokinetics and CYP3A5 Pharmacogenetics for Once- Versus Twice-Daily Tacrolimus from First Dosing Day to 1 Year Post-Transplantation

Background: Long term allograft survival remains poorer in African American(AA) renal transplant recipients(RTR) compared to Caucasians(C) and may be due to racial differences in calcineurin inhibitor pharmacology. P-glycoprotein(P-gp), an ABC transporter expressed in liver, gut, kidney and peripheral blood mononuclear cells(PBMCs), modulates tacrolimus(TAC) pharmacokinetics(PK) and intracellular pharmacology. This study evaluated PBMC P-gp function and TAC PK in 33 AA and 32 C male(M) and female(F) RTR who received TAC and mycophenolic acid.

Methods: A steady-state 12-hour PK study determined TAC trough(C0), dose-adjusted area under the concentration time curve 0-4 hours(AUC0-4), apparent clearance(CL) and lean body weight (LBW)-normalized CL in stable RTR >6 months post-transplant. TAC dosage was adjusted using C0 range of 4-9 ng/ml. P-gp function was quantified by flow cytometric measurement of cyclosporine (CYA, 2.5 [micro]M)-reversible efflux of P-gp substrate, DiOC2(3) by % change of Mean Fluorescent Intensity(MFI) with CYA(% [Delta]MFI-CYA) pre-TAC(0 hours), 4, 8 and 12 hours after TAC and evaluated with AUC % [Delta]MFI-CYA.

Results: Significant race-gender effects in TAC dose, CL, AUC and AUC%[Delta]MFI-CYA were noted with reduced P-gp function and more rapid CL in AAF. P-gp function was a significant covariate influencing TAC AUC0-4(p=0.042).

 Mean[SD]  AAF  AAM  CF  CM  P Value
 eGFR[ml/min/1.74m2]  49.9(13.4)  57.4(13.4)  49.8(11.5)  64.4(16.2)  0.019
 Tac Dose[mg]  5.0(1.7)  3.7(1.6)  2.7(1.2)  2.2(0.7)  <0.001
 Tac C0[ng/ml]  7.2(1.8)  7.3(1.9)  6.7(1.7)  6.2(1.2)  NS
 CL[L/hr]  40.0(16.8) 28.2(13.3)  22.2(8.9)  21.3(6.7)  <0.001
 CL/LBW  0.81(0.35)  0.45(0.24)  0.48(0.20)  0.32(0.10)  <0.001
 Tac AUC0-4/Dose[ng.hr/ml/mg]  13.9(6.9)  18.8(8.9)  24.2(12.4)  21.3(7.7)  0.027
  AUC%ΔMFI-CYA  649(281)  945(440)  1393(1071)  1088(601)  0.029

Conclusion: P-gp function is associated with a race-gender effect and reduced P-gp function in AA. Clinical use of troughs to adjust TAC dose does not consider factors that influence variability in intracellular TAC concentration. P-glycoprotein function assessment may provide insight into more individualized tacrolimus immunosuppression among RTR.

CITATION INFORMATION: Tornatore K, Minderman H, Attwood K, O'Loughlin K, Venuto R. P-Glycoprotein Function: Association with Race, Gender and Tacrolimus Pharmacokinetics. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tornatore K, Minderman H, Attwood K, O'Loughlin K, Venuto R. P-Glycoprotein Function: Association with Race, Gender and Tacrolimus Pharmacokinetics. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/p-glycoprotein-function-association-with-race-gender-and-tacrolimus-pharmacokinetics/. Accessed March 6, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
    • Factors Influencing Creatinine Rise Following Donor Nephrectomy

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.